| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP)
|
Sanz, Miguel A.
|
|
2011
|
14 |
1 |
p. 90-96
7 p.
|
artikel
|
| 2 |
Can we account for selection bias? A comparison between bare metal and drug-eluting stents
|
De Ridder, Annemieke
|
|
2011
|
14 |
1 |
p. 3-14
12 p.
|
artikel
|
| 3 |
Copyright/Subscription
|
|
|
2011
|
14 |
1 |
p. A4-
1 p.
|
artikel
|
| 4 |
Cost-effectiveness analysis of LHRH agonists in the treatment of metastatic prostate cancer in Italy
|
Iannazzo, S.
|
|
2011
|
14 |
1 |
p. 80-89
10 p.
|
artikel
|
| 5 |
Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non–ST-segment elevation acute coronary syndromes
|
Schwenkglenks, Matthias
|
|
2011
|
14 |
1 |
p. 24-33
10 p.
|
artikel
|
| 6 |
Cost-effectiveness of infliximab for the treatment of active and progressive psoriatic arthritis
|
Cummins, Ewen
|
|
2011
|
14 |
1 |
p. 15-23
9 p.
|
artikel
|
| 7 |
Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms
|
Iyer, Shrividya S.
|
|
2011
|
14 |
1 |
p. 177-183
7 p.
|
artikel
|
| 8 |
Exact method for computing absolute percent change in a dichotomous outcome from meta-analytic effect size: Improving impact and cost-outcome estimates
|
Miller, Ted R.
|
|
2011
|
14 |
1 |
p. 144-151
8 p.
|
artikel
|
| 9 |
Impact of ACE inhibitors on mortality and morbidity in patients with AMI: Does tissue selectivity matter?
|
Kalsekar, Iftekhar
|
|
2011
|
14 |
1 |
p. 184-191
8 p.
|
artikel
|
| 10 |
Incremental cost-effectiveness of various monthly doses of vardenafil
|
Aspinall, Sherrie L.
|
|
2011
|
14 |
1 |
p. 97-101
5 p.
|
artikel
|
| 11 |
Instructions for Authors
|
|
|
2011
|
14 |
1 |
p. A7-A8
nvt p.
|
artikel
|
| 12 |
ISPOR code of ethics
|
|
|
2011
|
14 |
1 |
p. A6-
1 p.
|
artikel
|
| 13 |
Is the Health Utilities Index 3 valid for patients with ankylosing spondylitis?
|
Gooch, Katherine
|
|
2011
|
14 |
1 |
p. 160-165
6 p.
|
artikel
|
| 14 |
Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003
|
Cipriano, Lauren E.
|
|
2011
|
14 |
1 |
p. 41-52
12 p.
|
artikel
|
| 15 |
Metric properties of the MacDQoL, individualized macular-disease-specific quality of life instrument, and newly identified subscales in French, German, Italian, and American populations
|
Berdeaux, Gilles
|
|
2011
|
14 |
1 |
p. 110-120
11 p.
|
artikel
|
| 16 |
Preventable hospital admissions related to medication (HARM): Cost analysis of the HARM study
|
Leendertse, Anne J.
|
|
2011
|
14 |
1 |
p. 34-40
7 p.
|
artikel
|
| 17 |
Reconsidering the value of rehabilitation for patients with cerebrovascular disease in Japanese acute health care hospitals
|
Kuwabara, Kazuaki
|
|
2011
|
14 |
1 |
p. 166-176
11 p.
|
artikel
|
| 18 |
Screenee perception and health-related quality of life in colorectal cancer screening: A review
|
Pizzo, Elena
|
|
2011
|
14 |
1 |
p. 152-159
8 p.
|
artikel
|
| 19 |
Table of contents
|
|
|
2011
|
14 |
1 |
p. A1-A3
nvt p.
|
artikel
|
| 20 |
The CHD challenge: Comparing four cost-effectiveness models
|
Turner, David
|
|
2011
|
14 |
1 |
p. 53-60
8 p.
|
artikel
|
| 21 |
The cost-utility analysis of adult male circumcision for prevention of heterosexual acquisition of HIV in men in sub-Saharan Africa: a probabilistic decision model
|
Uthman, Olalekan A.
|
|
2011
|
14 |
1 |
p. 70-79
10 p.
|
artikel
|
| 22 |
The economic burden of Medicare-eligible patients by multiple sclerosis type
|
Gilden, Daniel M.
|
|
2011
|
14 |
1 |
p. 61-69
9 p.
|
artikel
|
| 23 |
The use of instrumental variables: An alternative to traditional modeling?
|
Neyt, Mattias
|
|
2011
|
14 |
1 |
p. 1-2
2 p.
|
artikel
|
| 24 |
The value of budget impact analyses in evaluating targeted therapies—The case of RSV prophylaxis for preterm infants
|
Krilov, Leonard
|
|
2011
|
14 |
1 |
p. 201-202
2 p.
|
artikel
|
| 25 |
Uncertainty analysis is inherently Bayesian
|
Stevens, John W.
|
|
2011
|
14 |
1 |
p. 202-203
2 p.
|
artikel
|
| 26 |
Uncertainty analysis is inherently Bayesian—Reply to letter to the editor by John Stevens
|
Barendregt, Jan J.
|
|
2011
|
14 |
1 |
p. 203-204
2 p.
|
artikel
|
| 27 |
Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain
|
Carreño, Agata
|
|
2011
|
14 |
1 |
p. 192-200
9 p.
|
artikel
|
| 28 |
Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals
|
Tosh, Jonathan C.
|
|
2011
|
14 |
1 |
p. 102-109
8 p.
|
artikel
|
| 29 |
Valuing health across the lifespan: Health state preferences for seasonal influenza illnesses in patients of different ages
|
Prosser, Lisa A.
|
|
2011
|
14 |
1 |
p. 135-143
9 p.
|
artikel
|
| 30 |
Valuing pharmacogenetic testing services: A comparison of patients' and health care professionals' preferences
|
Payne, Katherine
|
|
2011
|
14 |
1 |
p. 121-134
14 p.
|
artikel
|
Tijdschrift beschrijving